Elon Musk Says Neuralink's Blindsight Implant Is Ready From an Engineering Standpoint

Elon Musk wrote on X on October 29, 2026 that Blindsight, Neuralink's implant for restoring sight, "is ready from an engineering standpoint" and is now waiting on regulatory approval. He posted at 9:10 PM Arizona time and wrote that the device will "enable even those who are completely blind or have never seen to see."

Blindsight works around the eye. A camera films the scene and sends it wirelessly to an implant in the visual cortex, the part of the brain that turns signals into sight, and the implant's electrodes stimulate those cells to produce phosphenes, small points of light that together form a rough picture. Because the eye and the optic nerve play no part, the approach could help people who have lost both eyes, as long as the visual cortex is intact. Neuralink announced on September 17, 2024 that the United States Food and Drug Administration (FDA) had given Blindsight a Breakthrough Device Designation, a status that can speed the agency's review.

Minutes before the Blindsight post, Elon wrote that Telepathy, Neuralink's first product, "enables high-speed communication with computers or humans simply by thinking." Telepathy gives Blindsight a surgical track record to build on. Neura Pod, Elon, Explained's sister site and the ground-truth tracker for Neuralink facts, counts 27+ people with Neuralink implants as of October 2026.

The hardware keeps getting denser, and density matters most for sight, because more electrodes mean more points of light and a sharper picture. Neuralink's standard N1 implant carries 1,024 electrodes, and in September 2026 Neuralink confirmed a 3,000-channel implant in a participant in VOICE, its speech-restoration study, according to Neura Pod's September 2026 update. Neuralink has said future devices, Blindsight among them, will carry more than 10,000 channels.

Neura Pod's Blindsight trial guide expects the first participants to be adults between roughly 22 and 75 with profound blindness and a visual cortex that a magnetic resonance imaging (MRI) scan shows is intact. Neuralink's trial page already invites blind people to join a patient registry to hear when United States trials open.

With the engineering done in Elon's telling, the next milestone for Blindsight is approval for its first human implant, which would bring Neuralink's second product to its first patient.